Zobrazeno 1 - 10
of 155
pro vyhledávání: '"Crew KD"'
Autor:
Ruff P, Cubasch H, Joffe M, Rosenbaum E, Murugan N, Tsai MC, Ayeni O, Crew KD, Jacobson JS, Neugut AI
Publikováno v:
Cancer Management and Research, Vol Volume 10, Pp 279-286 (2018)
Paul Ruff,1,2 Herbert Cubasch,2,3 Maureen Joffe,2,4 Evan Rosenbaum,5 Nivashni Murugan,2,3 Ming-Chih Tsai,2,3 Oluwatosin Ayeni,2 Katherine D Crew,5–7 Judith S Jacobson,6,7 Alfred I Neugut5–7 1Division of Medical Oncology, Department of Internal Me
Externí odkaz:
https://doaj.org/article/62a72ba901c14ecab3ac24dbc92ae676
Autor:
Jones, T, Trivedi, MS, Jiang, X, Silverman, T, Underhill, M, Chung, WK, Kukafka, R, Crew, KD, Trivedi, M S, Chung, W K, Crew, K D
Publikováno v:
Journal of Cancer Education; Jun2021, Vol. 36 Issue 3, p463-469, 7p, 2 Charts, 1 Graph
Autor:
Hershman, DL, Unger, JM, Crew, KD, Awad, D, Dakhil, SR, Gralow, J, Greenlee, H, Lew, DL, Minasian, LM, Till, C, Wade, JL, Meyskens, FL, Moinpour, CM
Publikováno v:
Hershman, DL; Unger, JM; Crew, KD; Awad, D; Dakhil, SR; Gralow, J; et al.(2015). Randomized multicenter placebo-controlled trial of omega-3 fatty acids for the control of aromatase inhibitor-Induced musculoskeletal pain: SWOG S0927. Journal of Clinical Oncology, 33(17), 1910-1917. doi: 10.1200/JCO.2014.59.5595. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/4s57b8g4
© 2015 by American Society of Clinical Oncology. Purpose: Musculoskeletal symptoms are the most common adverse effects of aromatase inhibitors (AIs) and can result in decreased quality of life and discontinuation of therapy. Omega-3 fatty acids (O3-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::59d137bdb39ee731e9b47b5e31550437
http://www.escholarship.org/uc/item/4s57b8g4
http://www.escholarship.org/uc/item/4s57b8g4
Autor:
Hershman, DL, Unger, JM, Crew, KD, Moinpour, CM, Minasian, LM, Hansen, L, Lew, DL, Kaberle, K, Wade, JL, Meyskens, FL
Publikováno v:
Hershman, DL; Unger, JM; Crew, KD; Moinpour, CM; Minasian, LM; Hansen, L; et al.(2011). A Randomized Double Blind Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor (Al)-Induced Musculoskeletal Pain in Women with Early Stage Breast Cancer.. CANCER RESEARCH, 71. doi: 10.1158/0008-5472.SABCS11-OT2-07-02. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/4sd0q685
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::e738664aa624b2566334e1ec70b58294
http://www.escholarship.org/uc/item/4sd0q685
http://www.escholarship.org/uc/item/4sd0q685
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Crew KD, Shane E, Cremers S, McMahon DJ, Irani D, Hershman DL, Crew, Katherine D, Shane, Elizabeth, Cremers, Serge, McMahon, Donald J, Irani, Dinaz, Hershman, Dawn L
Publikováno v:
Journal of Clinical Oncology; 5/1/2009, Vol. 27 Issue 13, p2151-2156, 6p
Autor:
Hershman DL, McMahon DJ, Crew KD, Cremers S, Irani D, Cucchiara G, Brafman L, Shane E, Hershman, Dawn L, McMahon, Donald J, Crew, Katherine D, Cremers, Serge, Irani, Dinaz, Cucchiara, Gina, Brafman, Lois, Shane, Elizabeth
Publikováno v:
Journal of Clinical Oncology; 10/10/2008, Vol. 26 Issue 29, p4739-4745, 7p
Publikováno v:
Journal of Clinical Oncology; 9/1/2007, Vol. 25 Issue 25, p3877-3883, 7p
Autor:
Lichtenstein MRL; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Campbell P; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY., Raghunathan R; Mailman School of Public Health, Columbia University Irving Medical Center, New York, NY., Beauchemin M; Mailman School of Public Health, Columbia University Irving Medical Center, New York, NY., Elkin EB; Mailman School of Public Health, Columbia University Irving Medical Center, New York, NY., Crew KD; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY., Accordino M; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY., Ippoliti C; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY., Hwang M; Merck & Co, Rahway, NJ., Abramova R; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY., Harden E; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY., Kelly P; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY., Collins N; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY., Faheem K; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY., Wright JD; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, NY., Hershman DL; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2024 Sep 30, pp. OP2400326. Date of Electronic Publication: 2024 Sep 30.